Washington GLP-1 Lawsuit Overview
If you live in Washington and were diagnosed with NAION (Non-Arteritic Anterior Ischemic Optic Neuropathy) after taking a GLP-1 drug such as Ozempic, Wegovy, Mounjaro, Zepbound, Trulicity, or Rybelsus, you may be eligible to file a claim in the federal GLP-1 NAION MDL (MDL 3163).
All GLP-1 NAION claims — regardless of where the plaintiff lives — are consolidated in MDL 3163 in the Eastern District of Pennsylvania under Judge Karen Marston. You do not need to travel to Pennsylvania to file. Your local attorney can handle your case as part of the MDL.
3 Years
discovery
Washington Statute of Limitations Details
Washington generally applies a 3-year injury period and uses discovery-rule analysis where injury causation was not reasonably known earlier.
Who Qualifies in Washington?
To file a GLP-1 NAION claim as a Washington resident, you generally need:
- A documented prescription for Ozempic, Wegovy, Rybelsus, Mounjaro, Zepbound, or Trulicity
- An ophthalmologist's diagnosis of NAION or sudden optic nerve-related vision loss
- NAION developed during or after your GLP-1 drug use (not before)
- Filing within Washington's 3-year statute of limitations window
How the MDL Works for Washington Residents
Even though MDL 3163 is located in Pennsylvania, Washington residents can participate without traveling. Here's how:
- You hire a Washington-licensed attorney or a national mass tort firm
- Your case is filed in the MDL in Pennsylvania (or transferred there)
- All major MDL proceedings are handled by the Plaintiffs' Steering Committee
- You participate through your attorney, primarily via written correspondence and phone
- If your case goes to individual trial, it may be remanded to a federal court in Washington
Washington State Bar Resources
To find a licensed attorney in Washington, you can use the official state bar's attorney referral service:
Neighboring State Resources
Key Cities in Washington
GLP-1 drug users across Washington — including Seattle, Spokane, Tacoma, Vancouver, Bellevue — are eligible to participate in MDL 3163 regardless of their city.